跳至主要内容
临床试验/NCT07312669
NCT07312669已完成不适用

ROP Check Premature Infant Outcomes

Alaska Blind Child Discovery1 个研究点 分布在 1 个国家目标入组 7,070 人开始时间: 2010年1月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
7,070
试验地点
1
主要终点
ROP treatment: After examination, whether an infant reaching criteria for treatment and what treatment was given. Document the number and the proportion needing treatment.

研究概览

简要总结

The goal of this observation of multi-centered care of infants covered by ROP Check cloud-based database is to compare demographic and clinical risk factors to evaluate and improve vision-protecting guidelines.

详细描述

Infants from multiple academic and community hospital neonatal intensive care units (NICUs) and their covering ophthalmologists had the serial eye examination and treatment data covered by ROP Check® cloud-based database. ROP Check assists neonatologists to implement guideline scheduling of infants according to the American Academy of Pediatrics (AAP). Outcome included progression to Type 1 retinopathy of prematurity (ROP) and treatment details such as intra-vitreal anti-VEGF injection and peripheral ablative laser. demographic data including birthweight, gestational age, gender, race/ethnicity are analyzed to determine risk factors severe ROP. Blindness-preventing guidelines are reviewed, analyzed and evidence-based updates are proposed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • NICU infants

排除标准

  • Term birth

结局指标

主要结局

ROP treatment: After examination, whether an infant reaching criteria for treatment and what treatment was given. Document the number and the proportion needing treatment.

时间窗: 2010 through 2022

Type 1 ROP

次要结局

未报告次要终点

研究者

发起方
Alaska Blind Child Discovery
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验